NYSE : IGI
$0.07 (0.44%)
NYSE
Kenneth Donald Fuller
Asset Management
Financial Services
IGI
N/A
US
USD
800-822-5544
95790A101
0001462586
0.00
0.01
0.01
0.01
0.00
$4.14M
23.31
0.91
0.00
0.00
$1
$6M
145.02%
145.02%
5.74%
5.60%
16.16
-0.29
-0.29
3/5
0 Analysts
%
About Western Asset Investment Grade Defined Opportunity Trust Inc. (NYSE:IGI) Stock
The Western Asset Investment Grade Defined Opportunity Trust Inc. operates as a closed-end mutual fund concentrating on fixed income, initially established and overseen by Legg Mason Partners Fund Advisor, LLC. Its management is shared among several entities, including Western Asset Management Company, Western Asset Management Company Pte. Ltd, Western Asset Management Company Ltd., and Western Asset Management Company Limited. This U.S.-domiciled trust, formed on June 26, 2009, allocates its capital specifically within the fixed income markets of the United States. Its investment objective is to acquire securities from companies spanning a broad range of diversified sectors, with a primary focus on investment-grade corporate debt instruments possessing various maturity dates. All investme ... nt decisions are informed by the fund's proprietary in-house research. The trust is scheduled to liquidate on or around December 2, 2024.
IGI to Release Second Quarter and Half Year 2026 Financial Results on August 4, 2026
2026-07-07 09:00:00
HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it expects to release financial results for the second quarter and first half of 2026 on Tuesday, August 4, 2026, after the close of the U.S. financial markets. The results, along with an accompanying slide presentation, will be posted in the Investors section of the Company website at www.iginsure.com. The Company will host an investor teleconference, i.
2026-06-23 08:00:00
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Ichnos Glenmark Innovation, Inc. (IGI), a global clinical-stage biotechnology company focused on developing Multispecific™ antibodies in oncology, today announced the appointment of Mariana (Maya) Cota Stirner, M.D., Ph.D., as Chief Medical Officer.
2026-06-08 09:00:00
HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it has secured registration approval from the International Financial Services Centres Authority (IFSCA) to operate an IFSCA Insurance Office (IIO) in India's Gujarat International Finance Tec-City (“GIFT City”), India's first and only operational international financial services centre. IGI's India operation is a reinsurance branch of IGI's UK subsidiar.
2026-05-20 07:00:00
Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a 1st-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors
IGI Announces Increase in Quarterly Ordinary Common Share Dividend
2026-05-14 09:00:00
HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that its Board of Directors has voted to increase the Company's quarterly ordinary common share dividend to $0.075 per share, representing a 50% increase from the present rate of $0.05 per share per quarter. This marks the third consecutive year that the Company has increased the quarterly ordinary common share dividend. The first regular quarterly ordinary c.
CEF Market Weekly Review: The Key Factors Driving NII
2026-05-04 09:42:32
We review the CEF market valuation and performance through the fourth week of April and highlight recent market action. CEF markets faced renewed risk aversion, with sector discounts widening to historical averages and MLPs and Convertibles led to the upside. Western Asset CEFs' NII remained largely stable; key drivers include short-term rate direction, liability management, and overdistribution.
2026-04-29 08:00:00
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.
2026-04-22 09:00:00
HAMILTON, Bermuda--(BUSINESS WIRE)--International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it has filed its Annual Report on Form 20-F, which includes the Company's audited financial statements for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission (“SEC”). The report was filed on April 21, 2026 and can be found on IGI's website at www.iginsure.com in the Investors section under SEC Filings or on the SEC's websi.
Frequently Asked Questions
What is the current Western Asset Investment Grade Defined Opportunity Trust Inc. (IGI) stock price?
Western Asset Investment Grade Defined Opportunity Trust Inc.(NYSE:IGI) stock price is $16.09 in the last trading session. During the trading session, IGI stock reached the peak price of $17.09 while $15.78 was the lowest point it dropped to. The percentage change in IGI stock occurred in the recent session was 0.44% while the dollar amount for the price change in IGI stock was $0.07.
IGI's industry and sector of operation?
The NYSE listed IGI is part of Asset Management industry that operates in the broader Financial Services sector.
Who are the executives of IGI?
Kenneth Donald Fuller
| Chairman, Chief Executive Officer and President
|
|
|
|
How many employees does IGI have?
Number of IGI employees currently stands at None. IGI operates from One Madison Avenue, New York City, NY 10017, US.
Link for IGI official website?
How do I contact IGI?
IGI could be contacted at phone #800-822-5544 and can also be accessed through its website. IGI operates from One Madison Avenue, New York City, NY 10017, US.
How many shares of IGI are traded daily?
The average number of IGI shares traded daily for last 3 months was 18.02K.
What is the market cap of IGI currently?
The market value of IGI currently stands at $96.44M with its latest stock price at $16.09